Explore the full directors' dealings record of 삼일제약, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Market capitalisation: €205.7bn. The latest transaction was reported on 6 May 2026 — Purchase. Among the most active insiders: 허승범. All data is free.